Cargando…

Risk Factors for 30- and 90-Day Readmission due to Intestinal Bowel Obstruction after Posterior Lumbar Fusion

STUDY DESIGN: A retrospective analysis of data from the Healthcare Cost and Utilization Project Nationwide Readmissions Database (HCUP-NRD). PURPOSE: To identify the perioperative characteristics associated with 30-day and 90-day readmission due to intestinal bowel obstructions (IBOs) following post...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mikhail, Christopher Mina, Warburton, Andrew, Girdler, Steven Joseph, Platt, Samantha, Cong, Guang-Ting, Cho, Samuel Kang-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Spine Surgery 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561157/ https://www.ncbi.nlm.nih.gov/pubmed/33108851 http://dx.doi.org/10.31616/asj.2020.0085

Ejemplares similares

Determining the Factors Associated With 30- and 90-day Readmissions Following Plastic Surgery Within the National Readmissions Database
por: Sayegh, Farah, et al.
Publicado: (2020)

Risk Factors Affecting 90-day Readmission of Patients with Inflammatory Bowel Disease
por: Ghahramani, Sulmaz, et al.
Publicado: (2022)

Diabetes Is Predictive of Postoperative Outcomes and Readmission Following Posterior Lumbar Fusion
por: Arrighi-Allisan, Annie E., et al.
Publicado: (2020)

Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study
por: Alqahtani, Jaber S, et al.
Publicado: (2021)

SAT-628 Risk Factors Associated with 30-Day and 90-Day Readmission in Persons with Diabetic Foot Ulcers
por: Dawkins, Makeda, et al.
Publicado: (2020)

Ninety-Day Readmission in Elective Revision Lumbar Fusion Surgery in the Inpatient Setting
por: Hydrick, Thomas C., et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio predicts 30-, 90-, and 180-day readmissions of patients with hepatic encephalopathy
por: Zhang, Lin, et al.
Publicado: (2023)

Risk Factors for Unplanned Reoperation Within 30 Days Following Elective Posterior Lumbar Spinal Fusion
por: Durand, Wesley M., et al.
Publicado: (2017)

Comparative Analysis of 30-Day Readmission, Reoperation, and Morbidity between Posterior Cervical Decompression and Fusion Performed in Inpatient and Outpatient Settings
por: Song, Junho, et al.
Publicado: (2023)

Thirty-Day Perioperative Complications, Prolonged Length of Stay, and Readmission Following Elective Posterior Lumbar Fusion Associated With Poor Nutritional Status
por: Phan, Kevin, et al.
Publicado: (2018)

Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease
por: Micic, Dejan, et al.
Publicado: (2017)

Response to: Comparative Analysis of 30-Day Readmission, Reoperation, and Morbidity between Posterior Cervical Decompression and Fusion Performed in Inpatient and Outpatient Settings
por: Song, Junho, et al.
Publicado: (2023)

Letter to the Editor: Comparative Analysis of 30-Day Readmission, Reoperation, and Morbidity between Posterior Cervical Decompression and Fusion Performed in Inpatient and Outpatient Settings
por: Mohammadi, Esmaeil, et al.
Publicado: (2023)

Analysis of 90-Day Readmissions After Total Shoulder Arthroplasty
por: Chung, Andrew S., et al.
Publicado: (2019)

Predictors of 90-day Colonic Diverticular Recurrent Bleeding and Readmission
por: Kitagawa, Tomoyuki, et al.
Publicado: (2019)

Incidence, reasons, and risk factors for 30-day readmission after lumbar spine surgery for degenerative spinal disease
por: Cho, Pyung Goo, et al.
Publicado: (2020)

Risk Factors for 30-day Unplanned Readmission following Surgery for Lumbar Degenerative Diseases: A Systematic Review
por: Chen, Liang-Yi, et al.
Publicado: (2022)

Risk factors for 90-day readmission in veterans with inflammatory bowel disease—Does post-discharge follow-up matter?
por: Malhotra, Ashish, et al.
Publicado: (2018)

High Mortality among 30-Day Readmission after Stroke: Predictors and Etiologies of Readmission
por: Nouh, Amre M., et al.
Publicado: (2017)

Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
por: Yang, Sara, et al.
Publicado: (2022)

Autologous Breast Reconstruction is Associated with Lower 90-day Readmission Rates
por: Sawyer, Justin D., et al.
Publicado: (2022)

The 90-Day Reoperations and Readmissions in Complex Adult Spinal Deformity Surgery
por: Lee, Nathan J., et al.
Publicado: (2020)

Readmission After COPD Exacerbation Scale: determining 30-day readmission risk for COPD patients
por: Lau, Christine SM, et al.
Publicado: (2017)

“Weekend Effect” on 30-Day Readmissions among Stroke Survivors: An Analysis of the National Readmission Database
por: Khaksari, Bijan J., et al.
Publicado: (2019)

Examining 30-day COPD readmissions through the emergency department
por: Rezaee, Michael E, et al.
Publicado: (2017)

Paracentesis in cirrhotics is associated with increased risk of 30-day readmission
por: Sobotka, Lindsay A, et al.
Publicado: (2018)

The Impact of Ischaemic Stroke Subtype on 30-day Hospital Readmissions
por: Bjerkreim, Anna Therese, et al.
Publicado: (2018)

Patient vs provider perspectives of 30-day hospital readmissions
por: Smeraglio, Andrea, et al.
Publicado: (2019)

The relationship between diabetes mellitus and 30-day readmission rates
por: Ostling, Stephanie, et al.
Publicado: (2017)

Medication adherence as a predictor of 30-day hospital readmissions
por: Rosen, Olga Z, et al.
Publicado: (2017)

Avoidable 30‐day readmissions in patients undergoing vascular surgery
por: Knighton, A., et al.
Publicado: (2019)

187. The 30-Day Readmission and 30-Day Mortality of Hemodialysis Patients with Antibiotic-Resistant Gram-Negative Bacteremia
por: Oommen, Jomi K, et al.
Publicado: (2019)

Reduction in 90 day readmission rates utilizing ambulatory pulmonary pressure monitoring
por: Valika, Ali, et al.
Publicado: (2022)

Association of glucose variability at the last day of hospitalization with 30-day readmission in adults with diabetes
por: Spanakis, Elias K, et al.
Publicado: (2020)

Readmission Risk Assessment Tool (RRAT) for Decreasing 30-Day Readmission Rates in Total Joint Arthroplasty (TJA) and Predicting Readmission
por: Dundon, John, et al.
Publicado: (2023)

B‐Type Natriuretic Peptide Predicts 30‐Day Readmission for Heart Failure but not Readmission for Other Causes
por: Flint, Kelsey M., et al.
Publicado: (2014)

Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale
por: Chamberlain, Ronald S, et al.
Publicado: (2018)

Sex‐Based Differences in 30‐Day Readmissions After Cardiac Arrest: Analysis of the Nationwide Readmissions Database
por: Sobti, Navjot Kaur, et al.
Publicado: (2022)

Real-world evidence on impact of a pharmacist-led transitional care program on 30- and 90-day readmissions after acute care episodes
por: Bae-Shaaw, Yuna H, et al.
Publicado: (2020)

Developing a Predictive Tool for Hospital Discharge Disposition of Patients Poststroke with 30-Day Readmission Validation
por: Cho, Jin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s33jqu6s8a62ouudgmegt2ugs5